Kineticos Life Sciences

Overview

Kineticos Life Sciences is a venture capital firm dedicated to advancing scientific research and improving patient outcomes by investing in life science companies. Their focus spans various sectors, including specialized pharmaceutical services, tools and equipment, and innovative treatments for diseases such as cancer, neurodegenerative disorders, and rare diseases. The firm also addresses global health challenges like antimicrobial resistance through targeted investments. The firm's investment strategy encompasses multiple stages, from seed to growth, targeting high-growth opportunities across the life sciences ecosystem. Kineticos Life Sciences employs a hands-on approach, leveraging deep scientific and business expertise to support management teams at every step of the business lifecycle. This includes providing strategic guidance, operational support, and access to a network of industry experts to drive value creation. With a team of seasoned life sciences operators, executives, and investors, Kineticos Life Sciences has a track record of successful exits and a commitment to fostering innovation in the healthcare sector. Their portfolio includes companies utilizing disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi, all aimed at transforming medical practices and improving patient care. Kineticos Life Sciences is headquartered in Raleigh, North Carolina, and operates with a team of professionals dedicated to identifying and nurturing companies that offer unique, innovative, and IP-protected products and services. Their mission is to create a world without cancer, rare and neurodegenerative diseases, and antimicrobial resistance, aligning with their vision to make a significant impact on global health through strategic investments. The firm's approach is characterized by a partnership model that goes beyond traditional investment, offering consulting services to portfolio companies. These services include due diligence, market strategy development, competitive analysis, and pricing strategy, all aimed at accelerating the growth and success of their investee companies. This comprehensive support underscores Kineticos Life Sciences' commitment to driving sustainable and profitable growth in the life sciences industry. Kineticos Life Sciences' dedication to innovation and patient-centric solutions is evident in their diverse portfolio and strategic initiatives. By focusing on unmet medical needs and leveraging cutting-edge technologies, they continue to play a pivotal role in advancing healthcare and improving patient outcomes globally. Their investment philosophy is rooted in a deep understanding of the life sciences sector, enabling them to identify and support companies with the potential to make a meaningful impact. Through strategic investments and active collaboration, Kineticos Life Sciences contributes to the advancement of medical research and the development of transformative therapies. In summary, Kineticos Life Sciences stands as a prominent venture capital firm in the life sciences sector, committed to fostering innovation, supporting entrepreneurs, and driving advancements that lead to improved patient outcomes worldwide. Their strategic focus, comprehensive support, and dedication to addressing global health challenges position them as a key player in the healthcare investment landscape.

Investment Focus

• Innovative life science companies
• Focus on oncology, neurosciences, rare diseases, and antimicrobial resistance
• Utilization of disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi
• Unique, innovative, and IP-protected products and services

Portfolio Companies